PDL BioPharma Inc.


in
PDL BioPharma Inc. reported earnings results for the fourth quarter and full year ended December 31, 2007. Total revenues for the fourth quarter of 2007 were $49.8 million compared to $59.8 million in the same period of 2006. GAAP net loss for the fourth quarter of 2007 was $15.6 million, or $0.13 per basic and diluted share, compared with a GAAP net loss of $89.7 million, or $0.78 per basic and diluted share, for the comparable 2006 period.